AQST

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Dividends

Explore dividend yields, payout ratios, and historical trends to maximize your investment strategies.

Dollar change -0.08
Percentage change -2.75	%

Index	-	P/E	-	EPS (ttm)	-0.43	Insider Own	12.52%	Shs Outstand	91.04M	Perf Week	-7.82%
Market Cap	257.64M	Forward P/E	-	EPS next Y	-0.41	Insider Trans	-0.65%	Shs Float	79.64M	Perf Month	-15.90%
Income	-28.77M	PEG	-	EPS next Q	-0.11	Inst Own	39.17%	Short Float	7.76%	Perf Quarter	-33.25%
Sales	51.50M	P/S	5.00	EPS this Y	-262.39%	Inst Trans	-2.95%	Short Ratio	2.29	Perf Half Y	29.82%
Book/sh	-0.40	P/B	-	EPS next Y	14.03%	ROA	-30.15%	Short Interest	6.18M	Perf Year	22.51%
Cash/sh	1.05	P/C	2.71	EPS next 5Y	-	ROE	-	52W Range	1.25 - 6.23	Perf YTD	40.10%
Dividend Est.	-	P/FCF	-	EPS past 5Y	46.61%	ROI	-37.12%	52W High	-54.57%	Beta	2.82
Dividend TTM	-	Quick Ratio	5.85	Sales past 5Y	-4.81%	Gross Margin	60.23%	52W Low	126.15%	ATR (14)	0.23
Dividend Ex-Date	-	Current Ratio	6.28	EPS Y/Y TTM	37.05%	Oper. Margin	-37.77%	RSI (14)	33.64	Volatility	4.92% 6.42%
Employees	135	Debt/Eq	-	Sales Y/Y TTM	10.65%	Profit Margin	-55.85%	Recom	1.11	Target Price	8.61
Option/Short	Yes / Yes	LT Debt/Eq	-	EPS Q/Q	-259.47%	Payout	-	Rel Volume	1.28	Prev Close	2.91
Sales Surprise	-1.70%	EPS Surprise	-91.66%	Sales Q/Q	8.25%	Earnings	May 07 AMC	Avg Volume	2.70M	Price	2.83
SMA20	-11.50%	SMA50	-24.05%	SMA200	7.76%	Trades		Volume	1,755,238	Change	-2.75%

Date	Action	Analyst	Rating Change	Price Target Change
May-10-24	Initiated	Leerink Partners	Outperform	$8
Apr-11-24	Initiated	Piper Sandler	Overweight	$10
Mar-28-24	Initiated	Raymond James	Outperform	$7
Apr-07-21	Resumed	RBC Capital Mkts	Outperform	$7
Apr-22-19	Initiated	H.C. Wainwright	Buy
Jan-03-19	Initiated	Lake Street	Buy	$14
Aug-20-18	Initiated	RBC Capital Mkts	Outperform	$23
Aug-20-18	Initiated	JMP Securities	Mkt Outperform	$29

May-28-24 08:00AM	Aquestive Therapeutics to Present Anaphylm (epinephrine) Sublingual Film Pharmacokinetic and Pharmacodynamic Data At 2024 Eastern Allergy Conference (GlobeNewswire)
May-10-24 07:11AM	Leerink Partners Starts Aquestive Therapeutics With Outperform Rating, $8 Price Target (MT Newswires) -6.08%
May-09-24 04:51PM	Aquestive Therapeutics, Inc. (NASDAQ:AQST) Q1 2024 Earnings Call Transcript (Insider Monkey) +6.65%
08:00AM	Aquestive Therapeutics to Participate in The Citizens JMP Life Sciences Conference (GlobeNewswire)
03:05AM	Aquestive Therapeutics Inc (AQST) Q1 2024 Earnings Call Transcript Highlights: Navigating ... (GuruFocus.com)
09:57PM	Loading…
May-07-24 09:57PM	AQST Stock Earnings: Aquestive Therapeutics Misses EPS, Misses Revenue for Q1 2024 (InvestorPlace)
07:00PM	Compared to Estimates, Aquestive Therapeutics (AQST) Q1 Earnings: A Look at Key Metrics (Zacks)
05:25PM	Aquestive Therapeutics (AQST) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
04:29PM	Aquestive Therapeutics: Q1 Earnings Snapshot (Associated Press Finance)
04:19PM	Aquestive Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update (GlobeNewswire)
Apr-30-24 10:01AM	Analysts Estimate Aquestive Therapeutics (AQST) to Report a Decline in Earnings: What to Look Out for (Zacks) -10.04%
Apr-29-24 11:19AM	Aquestive Therapeutics Obtains FDA Approval for Libervant to Treat Seizure in Children (MT Newswires) -8.23%
07:00AM	Aquestive Therapeutics Receives U.S. FDA Approval and Market Access for Libervant (diazepam) Buccal Film in Pediatric Patients Ages 2 to 5 and Provides Update on Anaphylm (epinephrine) Sublingual Film (GlobeNewswire)
Apr-25-24 08:00AM	Aquestive Therapeutics to Report First Quarter 2024 Financial Results and Recent Business Highlights on May 7 and Host Conference Call on May 8 at 8:00 a.m. ET (GlobeNewswire)
Apr-17-24 08:00AM	Coming FDA Approvals Could Send These 3 Drug Stocks Soaring (InvestorPlace)
04:01PM	Loading…
Apr-12-24 04:01PM	Aquestive Therapeutics to Present Crossover Study Data for Libervant (diazepam) Buccal Film at 76th Annual Meeting of the American Academy of Neurology (GlobeNewswire)
Apr-02-24 06:15PM	Aquestive Therapeutics (AQST) Ascends While Market Falls: Some Facts to Note (Zacks)
Apr-01-24 08:00AM	Aquestive Therapeutics Strengthens Board of Directors with Experienced Biotech Executive (GlobeNewswire)
Mar-25-24 08:00AM	Aquestive Therapeutics Announces Closing of Underwritten Public Offering of Common Stock (GlobeNewswire)
Mar-22-24 06:00PM	Aquestive Therapeutics (AQST) Flat As Market Sinks: What You Should Know (Zacks)
Mar-20-24 08:46AM	Why Is Aquestive Therapeutics (AQST) Stock Down 14% Today? (InvestorPlace) -15.64%
Mar-19-24 09:49PM	Aquestive Therapeutics Announces Pricing of $75 Million Underwritten Public Offering of Common Stock (GlobeNewswire)
05:00PM	Insider Sell: Chief Innovation/Tech Officer Alexander Schobel Sells 50,000 Shares of Aquestive ... (GuruFocus.com)
04:01PM	Aquestive Therapeutics Announces Proposed Public Offering of Common Stock (GlobeNewswire)
Mar-18-24 11:47AM	Aquestive (AQST) Up as Anaphylm Pivotal Study Meets Goals (Zacks) -9.52%
06:46AM	Strength Seen in Aquestive Therapeutics (AQST): Can Its 16.0% Jump Turn into More Strength? (Zacks)
Mar-15-24 01:00PM	5 Growth Stocks Under $50 for March 2024 (Investopedia) +16.00%
Mar-14-24 05:23PM	Aquestive Therapeutics Announces Pivotal Study for Anaphylm (epinephrine) Sublingual Film Successfully Meets Primary and Secondary Endpoints and Provides Clinical Development Update Following FDA Meeting (GlobeNewswire)
Mar-12-24 05:00PM	Insider Sell: Chief Innovation/Tech Officer Alexander Schobel Sells 25,000 Shares of Aquestive ... (GuruFocus.com)
Mar-07-24 01:43PM	Aquestive Therapeutics Inc Reports Full Year 2023 Financial Results (GuruFocus.com) +12.92%
11:56AM	Loading…
11:56AM	Aquestive Therapeutics, Inc. (NASDAQ:AQST) Q4 2023 Earnings Call Transcript (Insider Monkey)
12:53AM	Q4 2023 Aquestive Therapeutics Inc Earnings Call (Thomson Reuters StreetEvents)
Mar-05-24 10:51PM	AQST Stock Earnings: Aquestive Therapeutics Misses EPS, Beats Revenue for Q4 2023 (InvestorPlace)
06:15PM	Aquestive Therapeutics (AQST) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
05:15PM	Aquestive Therapeutics: Q4 Earnings Snapshot (Associated Press Finance)
05:05PM	Aquestive Therapeutics Reports Full Year 2023 Financial Results and Provides Business Update (GlobeNewswire)
Mar-04-24 09:30AM	Wall Street Bulls Look Optimistic About Aquestive Therapeutics (AQST): Should You Buy? (Zacks)
Feb-29-24 06:00PM	Aquestive Therapeutics (AQST) Outperforms Broader Market: What You Need to Know (Zacks)
Feb-21-24 10:27AM	Aquestive (AQST) to Report Q4 Earnings: Here's What to Expect (Zacks) -5.28%
08:00AM	Aquestive Therapeutics to Report Fourth Quarter 2023 Financial Results and Recent Business Highlights on March 5 and Host Conference Call on March 6 at 8:00 a.m. ET (GlobeNewswire)
Feb-20-24 06:00PM	Aquestive Therapeutics (AQST) Registers a Bigger Fall Than the Market: Important Facts to Note (Zacks)
Feb-15-24 08:00AM	Aquestive Therapeutics to Present Anaphylm (epinephrine) Sublingual Film Pharmacokinetic and Pharmacodynamic Data at the 2024 AAAAI Annual Meeting (GlobeNewswire)
Feb-14-24 06:00PM	Aquestive Therapeutics (AQST) Rises Higher Than Market: Key Facts (Zacks)
Feb-08-24 06:00PM	Why Aquestive Therapeutics (AQST) Outpaced the Stock Market Today (Zacks)
Feb-02-24 06:00PM	Aquestive Therapeutics (AQST) Stock Sinks As Market Gains: Here's Why (Zacks)
Jan-30-24 08:00AM	Aquestive Therapeutics to Participate in Oppenheimer 34th Annual Healthcare Conference (GlobeNewswire)
Jan-26-24 06:00PM	Aquestive Therapeutics (AQST) Increases Despite Market Slip: Here's What You Need to Know (Zacks)
Jan-23-24 06:15PM	Aquestive Therapeutics (AQST) Stock Slides as Market Rises: Facts to Know Before You Trade (Zacks)
Jan-17-24 06:15PM	Aquestive Therapeutics (AQST) Declines More Than Market: Some Information for Investors (Zacks)
Jan-11-24 06:15PM	Here's Why Aquestive Therapeutics (AQST) Fell More Than Broader Market (Zacks)
Jan-03-24 08:10AM	Here's Why You Should Invest in Aquestive (AQST) Stock Now (Zacks)
Dec-29-23 09:40AM	Are Medical Stocks Lagging Aquestive Therapeutics (AQST) This Year? (Zacks)
Dec-13-23 09:40AM	Is Aquestive Therapeutics (AQST) Stock Outpacing Its Medical Peers This Year? (Zacks) +5.05%
Dec-05-23 08:00AM	Aquestive Therapeutics Doses First Patient in Phase 3 Pivotal Clinical Study Evaluating Pharmacokinetics and Pharmacodynamics of Anaphylm (epinephrine) Sublingual Film (GlobeNewswire)
Nov-29-23 09:55AM	Aquestive Therapeutics (AQST) Just Flashed Golden Cross Signal: Do You Buy? (Zacks)
Nov-27-23 12:00PM	Aquestive Therapeutics (AQST) Is Up 2.98% in One Week: What You Should Know (Zacks) -8.49%
09:40AM	Are Medical Stocks Lagging Aquestive Therapeutics (AQST) This Year? (Zacks)
Nov-16-23 12:00PM	Aquestive Therapeutics (AQST) Upgraded to Strong Buy: Here's What You Should Know (Zacks) +8.18%
Nov-10-23 09:40AM	Is Aquestive Therapeutics (AQST) Stock Outpacing Its Medical Peers This Year? (Zacks)
08:00AM	Aquestive Therapeutics to Present Positive Data from Pharmacokinetic and Pharmacodynamic Studies for Anaphylm at American College of Allergy Asthma and Immunology (ACAAI) Annual Meeting (GlobeNewswire)
Nov-08-23 02:58PM	Aquestive Therapeutics, Inc. (NASDAQ:AQST) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-06-23 05:55PM	Aquestive Therapeutics: Q3 Earnings Snapshot (Associated Press Finance)
05:54PM	Aquestive Therapeutics Inc (AQST) Reports 25% Year-Over-Year Growth in Year-to-Date Revenue (GuruFocus.com)
04:37PM	Aquestive Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update (GlobeNewswire)
Nov-02-23 08:00AM	Aquestive Therapeutics Completes $45 Million Debt Refinancing (GlobeNewswire) -6.49%
Nov-01-23 06:00PM	Aquestive Therapeutics (AQST) Stock Falls Amid Market Uptick: What Investors Need to Know (Zacks)
Oct-31-23 08:00AM	Aquestive Therapeutics to Report Third Quarter 2023 Financial Results and Recent Business Highlights on November 6 and Host Conference Call on November 7 at 8:00 a.m. ET (GlobeNewswire)
Oct-24-23 06:00PM	Aquestive Therapeutics (AQST) Beats Stock Market Upswing: What Investors Need to Know (Zacks)
Oct-09-23 06:15PM	Aquestive Therapeutics (AQST) Stock Sinks As Market Gains: Here's Why (Zacks)
08:00AM	Aquestive Therapeutics Provides Business Update (GlobeNewswire)
Oct-03-23 06:15PM	Aquestive Therapeutics (AQST) Stock Moves -0.71%: What You Should Know (Zacks)
Sep-27-23 06:15PM	Aquestive Therapeutics (AQST) Stock Sinks As Market Gains: What You Should Know (Zacks)
Sep-21-23 12:24PM	Aquestive (AQST) Up on Reaffirming Anaphylm Development Pathway (Zacks)
Sep-20-23 09:04AM	Aquestive Therapeutics Reaffirms Timeline and Pathway for Anaphylm (epinephrine) Sublingual Film (GlobeNewswire) +11.76%
Sep-15-23 06:00PM	Aquestive Therapeutics (AQST) Gains As Market Dips: What You Should Know (Zacks)
Sep-13-23 06:15PM	Aquestive Therapeutics (AQST) Flat As Market Gains: What You Should Know (Zacks)
Sep-12-23 08:26AM	Aquestive's (AQST) Libervant Accepted for FDA Review, Stock Up (Zacks) +5.73%
Sep-11-23 08:00AM	Aquestive Therapeutics Receives FDA Acceptance of New Drug Application (NDA) for Libervant (diazepam) Buccal Film in Pediatric Patients and Assignment of Prescription Drug User Fee Act (PDUFA) Date (GlobeNewswire)
Aug-23-23 08:00AM	Aquestive Therapeutics to Participate in Two Upcoming Investor Conferences (GlobeNewswire)
Aug-11-23 07:08AM	Aquestive Therapeutics, Inc.'s (NASDAQ:AQST) 11% loss last week hit both individual investors who own 60% as well as institutions (Simply Wall St.)
Aug-10-23 10:03AM	Aquestive Therapeutics, Inc. (NASDAQ:AQST) Q2 2023 Earnings Call Transcript (Insider Monkey)
Aug-07-23 05:40PM	Aquestive Therapeutics (AQST) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
04:38PM	Aquestive Therapeutics: Q2 Earnings Snapshot (AP Finance)
04:01PM	Aquestive Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Update (GlobeNewswire)
Aug-02-23 08:00AM	Aquestive Therapeutics to Participate in 2023 Wedbush PacGrow Healthcare Conference (GlobeNewswire)
Jul-27-23 07:00AM	Aquestive Therapeutics Announces Positive Topline Pharmacokinetic Data for Anaphylm (epinephrine) Sublingual Film (GlobeNewswire)
Jul-25-23 04:01PM	Aquestive Therapeutics to Report Second Quarter 2023 Financial Results and Recent Business Highlights on August 7 and Host Conference Call on August 8 at 8:00 a.m. ET (GlobeNewswire)
08:00AM	Aquestive Therapeutics to Present Positive Topline Data from Pharmacokinetic and Pharmacodynamic Studies of Anaphylm (epinephrine) Sublingual Film at Aspen Allergy Conference (GlobeNewswire)
Jul-21-23 06:00PM	Aquestive Therapeutics (AQST) Stock Sinks As Market Gains: What You Should Know (Zacks)
Jul-18-23 06:15PM	Aquestive Therapeutics (AQST) Outpaces Stock Market Gains: What You Should Know (Zacks)
Jul-14-23 09:40AM	Are Medical Stocks Lagging Aquestive Therapeutics (AQST) This Year? (Zacks)
Jul-12-23 06:15PM	Aquestive Therapeutics (AQST) Gains But Lags Market: What You Should Know (Zacks)
Jul-06-23 08:00AM	Aquestive Therapeutics to Present Positive Data from Pharmacokinetic and Pharmacodynamic Studies of Anaphylm (epinephrine) Sublingual Film at Global Food Allergy Prevention Summit (GlobeNewswire)
Jun-29-23 09:35AM	Down -31.17% in 4 Weeks, Here's Why Aquestive Therapeutics (AQST) Looks Ripe for a Turnaround (Zacks)
08:42AM	Aquestive Therapeutics Provides Business Update and Announces Chief Medical Officer Appointment (GlobeNewswire)
Jun-28-23 09:40AM	Are Medical Stocks Lagging Agios Pharmaceuticals (AGIO) This Year? (Zacks)
Jun-20-23 07:14PM	Alpine Immune Sciences, Inc. (ALPN) Soars 5.6%: Is Further Upside Left in the Stock? (Zacks) -5.09%
Jun-14-23 08:00AM	Investors in Aquestive Therapeutics (NASDAQ:AQST) have seen solid returns of 171% over the past year (Simply Wall St.)
Jun-12-23 09:40AM	Is Anebulo Pharmaceuticals (ANEB) Outperforming Other Medical Stocks This Year? (Zacks)
May-31-23 08:00AM	Aquestive Therapeutics Reports Positive Results from Latest Clinical Studies Evaluating Pharmacokinetic and Pharmacodynamic Performance of Anaphylm (epinephrine) Sublingual Film and Provides Findings from Recent Auto-Injector Clinical Study (GlobeNewswire) +12.14%

Aquestive Therapeutics, Inc. engages in the identifying, developing, and commercializing differentiated products to address unmet medical needs and to solve patients' therapeutic problems. Its product pipeline include Libervant, AQST-108, AQST-305, Suboxone and Zuplenz. The company was founded in January 2004 and is headquartered in Warren, NJ.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Schobel Alexander Mark	Chief Innovation/Tech Officer	Mar 15 '24	Sale	6.00	50,000	300,000	984,476	Mar 19 02:30 PM
Schobel Alexander Mark	Chief Innovation/Tech Officer	Mar 08 '24	Sale	5.19	25,000	129,685	1,040,371	Mar 12 01:45 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Aquestive Therapeutics Inc

Upgrade your FINVIZ experience